AzTrials
AzTrials

GingivitisNCT07551908

Evaluation of the Effect of the Mouthwash on Delicate Gums

A study testing Mouthwash for delicate gums in people with Gingivitis, run by Lacer S.A. at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this study is to learn if a mouthwash works to alleviate gingivitis in adults. It will also learn about the safety of the product. The main question it aims to answer is: Does the mouthwash help to improve signs of gingivitis? Participants will: Use mouthwash daily for 4 weeks Visit the clinic on the… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Gingivitis
What is being tested?
Mouthwash for delicate gums
Could I receive a placebo?
No, everyone receives an active treatment
How many people
33 participants
Where
1 siteSpain
Study dates
3 Mar 2026to 10 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy male and female subjects (with no specific repartition)
  • Subjects of Caucasian ethnicity
  • Subjects aged between 18 and 65 years (extremes included)
  • Subjects clinically showing moderate gums inflammation (gingivitis grade II, in particular all gingival scores for the mean should be between 1.75 and 2.3, according to Löe and Silness gingival scoring system), in particular:
  • 20% of the subjects with localized gingivitis (10-30% of evaluated sites with bleeding)
  • 80% of them with generalized gingivitis (>30% of evaluated sites with bleeding)
Show all 14Show fewer
  • Subjects with dental plaque (total plaque score at inclusion ≥2)
  • Subjects registered with the national health service
  • Subjects certifying the truthfulness of the personal data disclosed to the Principal Investigator or designated personnel
  • Subjects able to understand the language used in the investigation centre and the information given by the Principal Investigator or designated personnel
  • Subjects able to respect the instructions given by the Principal Investigator or designated personnel as well as able to respect the study constraints and specific requirements
  • Subjects who commit not to change their daily routine or lifestyle during the study
  • Subjects on stable pharmacological therapy (except for the pharmacological therapy in the non-inclusion criteria) for at least one month without any changes expected or planned during the study
  • Subjects informed about the test procedures who have signed a consent form and privacy agreement

Who cannot join

  • Subjects who do not meet the inclusion criteria
  • Smokers subjects
  • Subjects planning toothcare during the study period
  • Subjects using dental apparatus or using dental prosthesis, with generalized tooth recession, with presence of caries, with dental abscess or signs of periodontitis (periodontal probing depth >3mm) or active periodontitis
  • Subjects using other dental hygiene products than provided (e.g. dental floss, interdental brushes, mouthwash, etc) during the study period
  • Subjects with any acute, chronic, or progressive disease or condition that may interfere with the study data or that the Principal Investigator considers dangerous to the subject or incompatible with the requirements of the study
Show all 18Show fewer
  • Subjects participating or planning to participate in other clinical trials
  • Subjects who participated in a similar study without respecting an adequate washout period (at least one month)
  • Subjects that have intolerances or allergies to ingredients of the study product Page 8 of 28 Clinical Study Protocol: EC_0000149/2026 of 13/03/2026
  • Subjects under pharmacological treatments that are considered incompatible with the study requirement by the Principal Investigator
  • Subjects who are currently using products with the same activity as the study product, or who haven't observed an adequate washout period (at least one month)
  • Subjects admitted to a health or social facility
  • Subjects planning a hospitalization during the study
  • Subjects not able to be contacted in case of emergency
  • Subjects deprived of freedom by administrative or legal decision or under guardianship
  • Subjects who have or have had a history of alcohol or drug addiction
  • Subjects with eating disorders (i.e. bulimia, psychogenic eating disorders, etc.)
  • Subject breastfeeding, pregnant or not willing to take necessary precautions to avoid pregnancy during the study (for the women of childbearing potential).

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Clinica Dental Rob

    Badalona

Other trials in Spain

About this study

Official title: Evaluation of the Effect of a Cosmetic Product in Improving Gums Condition in Use Test Under Dentist Control.

The goal of this study is to learn if a mouthwash works to alleviate gingivitis in adults. It will also learn about the safety of the product. The main question it aims to answer is:

  • Does the mouthwash help to improve signs of gingivitis?

Participants will:

  • Use mouthwash daily for 4 weeks
  • Visit the clinic on the established days during 4 weeks for check-ups and evaluation
Conditions
Gingivitis
Being tested
Mouthwash for delicate gums
Medical subject headings
Gingivitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mouthwash for delicate gumsOther

    Mouthwash will be used 3 times a day after brushing during 4 weeks.

Study groups in NCT07551908
Study groupRoleWhat they receive
mouthwashExperimentalMouthwash will be used 3 times a day after brushing during 4 weeks.
Receives: Other: Mouthwash for delicate gums

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline in Gingival Index Score at 4 weeks

    The score is from 0 (normal gum) to 4 (severe inflammation, swelling, bleeding and presence of ulcers).

    Measured: From enrolment to the end of use at 4 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Apr 2026
  2. Study start3 Mar 2026
  3. Primary completion10 Jul 2026
  4. Study completion10 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07551908
Sponsor's protocol ID
IT0001492/26
Status last verified
Apr 2026
First submitted
16 Apr 2026
Last updated
26 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Only summary of the results to support the publication will be shared. No complete study documents will shared

Questions about this trial

What is this clinical trial studying?

A study testing Mouthwash for delicate gums in people with Gingivitis, run by Lacer S.A. at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 14 inclusion and 18 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline in Gingival Index Score at 4 weeks (time frame: From enrolment to the end of use at 4 weeks.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in